)
Visual
test
Saniona
Saniona (SANION) investor relations material
Saniona Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary24 Mar, 2026
Company overview and financial position
Focuses on neurological and psychiatric diseases with a partnership-driven business model.
Listed on NASDAQ Stockholm with a market cap of 2.6 BSEK ($285M) and strong cash reserves of 581 MSEK ($64M) at year-end 2025.
Holds 820 MSEK ($90M) in total assets, including near-term milestones and property.
Strategic pillars and market opportunity
Deep expertise in ion-channel drug discovery, validated by multiple collaborations and licensing deals.
Well-positioned to benefit from renewed industry interest in CNS disorders.
Targets high unmet needs in epilepsy and depression, which represent significant healthcare costs in the EU.
Pipeline and clinical development
Three prioritized assets: SAN2668 (paediatric epilepsy), SAN2219 (refractory focal epilepsy), SAN2465 (MDD/TRD), all advancing toward Phase 1 in late 2026.
Each asset is designed for subtype-selective GABA modulation to maximize efficacy and minimize side effects.
Additional partnered programs: ACP-711 (essential tremor, with Acadia) and SAN2335 (epilepsy, with Jazz Pharmaceuticals).
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Saniona
- Strong partnerships and pipeline progress drive growth, with key milestones expected soon.SANION
Life Science Conference 202618 Mar 2026 - Advancing three CNS programs with robust funding and strategic partnerships for clinical milestones.SANIONLife Science-dagen 20264 Mar 2026
- Full-year revenue and profit soared on partnership deals, with a robust pipeline set for clinical progress.SANIONQ4 202526 Feb 2026
- Advancing key programs and partnerships, with Tesofensine approval and new milestones expected.SANIONStatus Update19 Dec 2025
- Record Q3 revenue and profit fueled by licensing, with robust cash and pipeline momentum.SANIONQ3 202527 Nov 2025
- Advancing CNS pipeline with strong funding, major deals, and broad market ambitions.SANIONLife Science Summit 202519 Nov 2025
- Major licensing deals and strong cash position support pipeline advancement despite operating losses.SANIONQ2 202528 Aug 2025
- Transformational Acadia deal secures funding and advances Saniona's innovative pipeline.SANIONQ3 202413 Jun 2025
- Revenue growth and reduced losses position Saniona for potential regulatory and partnership milestones.SANIONQ2 202413 Jun 2025
Next Saniona earnings date
Q1 202627 May, 2026
Saniona
Next Saniona earnings date
Q1 202627 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage